Sun Pharmaceutical Industries, Inc.: H-1B filings and workplace records, Princeton, New Jersey
Sun Pharmaceutical Industries, Inc. filed 3 labor condition applications (LCA) in fiscal year 2026, to 30 June 2026. OFLC certified 2 of them. The median offered wage on its LCAs in fiscal years 2025 to 2026 is $116,839 a year. It filed 1 PERM application in fiscal year 2026, to 30 June 2026. OFLC certified it. An LCA is a filing. It is not a visa and it is not a job.
OSHA opened 1 inspection at Sun Pharmaceutical Industries, Inc. in New Jersey since 2016. The inspection has 2 citations. No citation is recorded as contested.
Is this the same company?
The site joins the records of each agency by employer name and by state. It has no other key.
A record on this page can belong to a different firm that has the same name.
Since the last update
No change. The site tracks the LCA filings, PERM applications, OSHA inspections and back wages of this employer record. Changes and data dates
H-1B and PERM: Office of Foreign Labor Certification
Decisions to Newest file fiscal year 2026, quarter 3Read from the committed copy
Employer-specific case information that appears on this website was provided to OFLC by employers who submitted prevailing wage, labor certification and labor attestation applications for processing. These are not employer responses to the Bureau of Labor Statistics' Occupational Employment Statistics (BLS-OES) survey.
Any typographical errors or other data anomalies (e.g., incomplete or blank data fields, etc.) may be due to internal data entry or other external customer errors in completing and submitting the applications for processing.
A small percentage of determinations may be subject to change in subsequent quarterly releases due to appeal or redetermination decisions on employer applications.
The words of the Office of Foreign Labor Certification. Source: Performance Data, read .
- LCA filings, fiscal year 2026
- 367% certified, year to date
- Median offered wage
- $116,839a year; prevailing $100,277
- Worker positions
- 19fiscal years 2025 to 2026
- PERM applications, fiscal year 2026
- 1100% certified
| Fiscal year | Filings | Certified | Certified share | Denied | Withdrawn |
|---|---|---|---|---|---|
| 2025 | 16 | 15 | 94% | 1 | 0 |
| 2026 | 3 | 2 | 67% | 0 | 1 |
| Job title | Median offered wage | LCA filings |
|---|---|---|
| Senior Director, Commercial Operations | No data | 2 |
| Senior Associate, Regulatory Affairs | No data | 2 |
| Supply Chain Analyst | No data | 1 |
| Director, Drug Safety | No data | 1 |
| Senior Manager, Regulatory Affairs | No data | 1 |
| Product Analyst | No data | 1 |
| Business Analyst | No data | 1 |
| Supply Planner | No data | 1 |
| Senior Manager, Business Transformation Office | No data | 1 |
| Sr. Manager, Incentive Compensation, Analytics and Reporting | No data | 1 |
| Sr. Associate, Regulatory Affairs - CMC | No data | 1 |
| Associate, Drug Safety | No data | 1 |
A wage is a year: the rate on the form times its unit, so an hourly rate times 2,080. A median needs three or more applications that state a wage. The list holds the twelve most frequent job titles.
Prevailing wage levels on the filings
| Level | Filings | Share |
|---|---|---|
| Level I | 3 | 16% |
| Level II | 4 | 21% |
| Level III | 5 | 26% |
| Level IV | 5 | 26% |
| Not stated | 2 | 11% |
| Occupation (SOC) | LCA filings | Median offered wage, all employers |
|---|---|---|
| Regulatory Affairs Specialists | 4 | $89,107 |
| Logisticians | 3 | $91,098 |
| Managers, All Other | 2 | $160,000 |
| Market Research Analysts and Marketing Specialists | 2 | $85,000 |
| General and Operations Managers | 2 | $134,920 |
| Management Analysts | 1 | $124,000 |
| Validation Engineers | 1 | $108,000 |
| Financial and Investment Analysts | 1 | $140,000 |
| Worksite state | LCA filings |
|---|---|
| New Jersey | 11 |
| New York | 7 |
| Massachusetts | 1 |
OFLC files an LCA under the state of the employer address on the form (New Jersey). The worksites can be in other states.
PERM applications (permanent labor certification)
| Fiscal year | Applications | Certified | Denied | Withdrawn |
|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 1 | 0 |
| 2026 | 1 | 1 | 0 | 0 |
| Job title | Applications |
|---|---|
| Senior Scientist, Analytical Chemistry | 1 |
| Manager, Portfolio Analysis | 1 |
| Occupation (SOC) | Applications |
|---|---|
| Chemists | 1 |
| Market Research Analysts and Marketing Specialists | 1 |
Fiscal year 2024 holds the applications on the new Form 9089 only.
OSHA inspections: Occupational Safety and Health Administration
Records to Inspections opened since 2016Read from the agency
Until cases are closed, IMIS entries concerning specific OSHA inspections are subject to continuing correction and updating, particularly with regard to citation items, which are subject to modification by amended citations, settlement agreements, or as a result of contest proceedings. THE USER SHOULD ALSO BE AWARE THAT DIFFERENT COMPANIES MAY HAVE SIMILAR NAMES AND CLOSE ATTENTION TO THE ADDRESS MAY BE NECESSARY TO AVOID MISINTERPRETATION.
The words of the Occupational Safety and Health Administration. Source: Establishment Search, read .
- Inspections since 2016
- 1
- Citations
- 22 serious, willful or repeat
- Current penalties
- $9,620initial $16,034
- Inspections with a contested citation
- 01 with a final order on every citation
| Year | Inspections | Citations | Current penalties |
|---|---|---|---|
| 2016 | 1 | 2 | $9,620 |
| All years | 1 | 2 | $9,620 |
| Opened | Citations | Status | Standards cited | Current penalty |
|---|---|---|---|---|
| 2 | Final order | 1910.23(a)(3)(ii) (Serious), 1910.24(e) (Serious) | $9,620 |
The status is for each inspection. "Contested" means that a citation has a contest date. "Final order" means that every citation has a final order date. Each date links to the inspection on osha.gov.
| Standard | Subject | Citations |
|---|---|---|
| 1910.23 | Ladders | 1 |
| 1910.24 | Step bolts and manhole steps | 1 |
| Measure | This record | NAICS 325 | New Jersey | United States |
|---|---|---|---|---|
| Citations for each inspection | 2.0 | 2.2 | 2.0 | 1.9 |
| Current penalty for each inspection | $9,620 | $6,796 | $7,847 | $3,760 |
| Inspections with a contested citation | 0% | No data | 7% | 8% |
No record at these agencies
Injury summaries
The Injury Tracking Application data for 2023 to 2025 has no Form 300A summary of this employer in New Jersey. Only establishments in covered industries with 20 or more employees must send one.
Calendar years 2023 to 2025. Read from the committed copy.
Back wages
The data since fiscal year 2005 has no concluded Wage and Hour Division case of this employer in New Jersey.
Concluded cases to . Cases since fiscal year 2005. Read from the agency.
Federal contracts
This employer is not among the 3,903 largest federal contract recipients of the latest 12 months that the site loads from USAspending.
Period the latest 12 months. Read from the agency.
Union elections
The site holds no NLRB election results at this time. nlrb.gov did not accept the requests of the site, so the copy is empty.
Data none, the copy on this site is empty. Not read from the agency.
Other employers in New Jersey
These links help you move through the records. The list is in name order. It is not a ranking.
Chemical Manufacturing in New Jersey
- Advanced Accelerator Applications USA, Inc.East Hanover
- Bionpharma Inc.Princeton
- Bristol-Myers Squibb CompanyPrinceton
- Cytec Industries, Inc.Princeton
- E.R. Squibb and Sons, LLC.Princeton
- Guardian Drug Company, Inc.Dayton
- Ingenus Pharmaceuticals Nj, LLCFairfield
- Novo Nordisk Research & Development US, Inc.Plainsboro
- Otsuka America Pharmaceutical, Inc.Princeton
- Otsuka Pharmaceutical Development & Commercialization, Inc.Princeton
- Shree Meldi Krupa LLCParsippany
- Teva Pharmaceuticals USA, Inc.Parsipanny
Questions about this record
- What happened to the LCAs of Sun Pharmaceutical Industries, Inc.?
- Sun Pharmaceutical Industries, Inc. filed 19 LCAs in fiscal years 2025 to 2026. OFLC certified 17 of them. OFLC denied 1. The employer withdrew 1.
- Which job title is most frequent on the LCAs of Sun Pharmaceutical Industries, Inc.?
- The job title Senior Director, Commercial Operations has 2 filings.
- Which prevailing wage levels do the LCAs state?
- The LCAs state Level I in 16%, Level II in 21%, Level III in 26% and Level IV in 26%, and no level in 11%. The employer states the level on the form.
- Are the OSHA citations of Sun Pharmaceutical Industries, Inc. final?
- The inspection has a final order on every citation. The current penalties are $9,620. The initial penalties were $16,034.
Official channels
- OSHAOSHA establishment searchOccupational Safety and Health Administration. Address checked .
- OFLCOFLC performance data (LCA and PERM disclosure files)Office of Foreign Labor Certification. Address checked .
- WHDHow to file a complaint with the Wage and Hour DivisionWage and Hour Division. Address checked .
Cite this page
Employer Ledger. "Sun Pharmaceutical Industries, Inc. (New Jersey)." https://employerledger.com/employer/sun-pharmaceutical-industries-inc-nj/. Records of: Office of Foreign Labor Certification; Occupational Safety and Health Administration. Newest record .
The address of this page does not change. The figures change when an agency publishes new records.
Where the figures come from
- OFLC Office of Foreign Labor Certification. Decisions to . Newest file fiscal year 2026, quarter 3. Read , from the committed copy.
- OSHA Occupational Safety and Health Administration. Records to . Inspections opened since 2016. Read , from the agency.
- 300A OSHA Injury Tracking Application, Form 300A. Calendar years 2023 to 2025. Read , from the committed copy.
- WHD Wage and Hour Division. Concluded cases to . Cases since fiscal year 2005. Read , from the agency.
- USAspending USAspending.gov. Period the latest 12 months. Read , from the agency.
The site built this page on . The methodology tells how records are matched and counted. To report an error in the processing, use the corrections page. The agency that holds a record decides disputes about it.